Latest Strategy News

Terragen Holdings has secured a major purchase order from Mort & Co Fertilisers for its Great Land Plus® bio-stimulant, projecting a significant sales boost in 2026. This deal underscores growing demand for sustainable agricultural solutions.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Genmin Limited has launched a A$25.7 million equity raising to advance its Baniaka iron ore project in Gabon, aiming for a final investment decision by mid-2026. The raise includes strategic collaboration with PowerChina and offers attaching options to investors.

BPH Global Ltd has reported a record-breaking month in its Indonesian seaweed operations, more than doubling previous sales and advancing its export capabilities.

Critica Limited has raised A$8 million in an oversubscribed placement to accelerate development of its Jupiter rare earths project, positioning itself as a key supplier of critical minerals for emerging technologies.

Lincoln Minerals Limited’s November 2025 AGM presentation highlights a significant copper-lead-zinc-silver discovery at its Minbrie Project, alongside progress in iron, graphite, and uranium assets across South Australia’s Eyre Peninsula.

Pengana Capital Group reports a steady increase in Funds Under Management to $3.84 billion as of October 2025, with a significant $69.1 million capital raise set to boost figures in November.

Pro Medicus Limited’s U.S. arm has secured a significant five-year, A$44 million contract to deploy its cloud-based Visage 7 imaging platform with Advanced Radiology Management, marking a strategic expansion in North America.

Locksley Resources has partnered with Columbia University to develop cutting-edge, sustainable technologies for rare earth and critical mineral processing in the US, advancing its Mine-to-Market strategy amid growing government support.

Patriot Resources reports significant copper-zinc-lead assay results from its Phase 1 trenching at Kitumba, Zambia, expanding the mineralised footprint fivefold and setting the stage for further exploration.

Island Pharmaceuticals has secured FDA confirmation that its antiviral Galidesivir can proceed under the Animal Rule pathway for Marburg virus, qualifying for a lucrative Priority Review Voucher. This regulatory milestone accelerates the drug’s path to approval and potential government stockpile inclusion.

Nexion Group has finalized the sale of its Nexion Networks and Blue Sky Telecom subsidiaries, pivoting its focus towards AI-driven business intelligence through Fuse Forward.